3D Tissue Models
Doubletree Hotel Philadelphia
237 South Broad Street
Philadelphia, PA

Schedule of Presentations:

Monday, February 22, 2010
07:30:00 check in
13:00:00 Registration
13:45:00 Workshop I: Improving Partnering to Ensure Optimal Drivers and Financial Benchmarks of Personalized Medicine
15:45:00 Workshop II: Patent Protection - A Key to Commercializing Personalized Medicine Brian McCaslin
17:30:00 Early Registration and Cocktail Reception
Tuesday, February 23, 2010
07:30:00 Registration
08:00:00 Chairperson's Opening Remarks
08:10:00 Companion Diagnostics: Poised to Take Center Stage in the Era of Personalized Medicine Gerald J. McDougall
08:45:00 Panel Session: Partnering Models in Personalized Medicine William J Welch, Bryan Dechairo, Joseph Ferrara, Mohan S. Iyer
09:15:00 Trends in the International Market for Advanced Personalized Diagnostics Harry Glorikian
09:45:00 Best practices for Pharmaceutical and Diagnostics/lab Companies in Partnering to Co-Develop Clinical Trials Biomarker and Commercial Companion Diagnostic Tests Brian Buxton
10:15:00 Morning Break/Networking/Exhibit Viewing
10:35:00 Alternative Partnering Models for Personalized Medicine Christopher Austin
11:05:00 Foundations for Personalized Medicine: Business Models in Action Keith Batchelder, Peter Miller
11:35:00 Pharma/Diagnostic Synergy in an Uncertain CDx World Keynote Presentation Stafford O'Kelly
12:05:00 Lunch
12:30:00 Diagnostic Company Presentations
13:00:00 Presentation TBA Mara G Aspinall
13:30:00 Integrated Technologies for Supporting Personalized Rx Discovery and Dx Development Manohar Furtado
14:00:00 Market Perspective and Learnings from a Global IVD Player Iain D. Miller
14:30:00 The Plying, the Pitch and the DNA Probe: How to do Companion Diagnostic Deals with Pharma Stephen Little
15:00:00 Refreshment Break/Exhibit Viewing
15:20:00 Personalized Healthcare: Mirage or Oasis Jason Coloma
15:20:00 Personalized Medicine Can Happen: A Diagnostics View Charles Raffin
15:30:00 Pharmaceutical Company Presentations
16:20:00 Merck’s Licensing Strategy – Oncology Partnerships and Personalized Medicine Linda Egger
16:50:00 Strengthening Big Pharma's Personalized Medicine Pipeline via Partnerships with Diagnostics Companies Cecilia Schott
17:20:00 Presentation TBA
Wednesday, February 24, 2010
07:15:00 check in
07:30:00 Registration
07:35:00 check in
07:35:00 welcome
08:00:00 Chairperson's Opening Remarks
08:10:00 Establishing Clinical Utility and Cost Effectiveness for Personalized Medicine Diagnostics: A PBM and Dx Partnership Bryan Dechairo
08:40:00 A Molecular Diagnostic (MDx) Perspective: Partnering MDx’s with Therapeutics (Rx’s) in Drug Development and Commercial Rx/MDx Launches William Welch
09:10:00 Bridging the Gap to Personalized Medicine: An FDA-Reform Managerial and Scientific Look at Regulations, Partnerships, Tools and Implications John A. Norris, Stephen Barnhill
10:10:00 Morning Break/Networking/Exhibit Viewing
10:30:00 FDA's Experience with Personalized Medicine Clearances & Approvals Elizabeth Mansfield
11:00:00 Getting Personalized Medicine Financed in Troubled Economic Times David Brunel
11:30:00 Partnering to Integrate Genomic Medicine into Clinical Care Ryan Phelan
12:00:00 Lunch
12:55:00 The Integration of Biomedical Technologies as a Requirement to Deliver Personalized Medicine David Lester
13:25:00 Presentation TBA
13:55:00 Panel Session: What Does the Future Hold for Personalized Medicine
14:00:00 End of the conference
About Us | Privacy Policy | Site Map | FAQs | Advertise With Us | Community
BiotechScienceNews.com promotes research and ranks life scientists working in the life science spectrum involving biotechnology,
drug discovery, genomics, microbiology, neuroscience, medicine, pharmacology, cell biology, and molecular biology.